6-苄基-5,6,7,8四氢吡咯并[4,3-D]嘧啶-4(3H)-酮
中文别名:
6-苄基-5,6,7,8-四氢吡啶并[4,3-D]嘧啶-4(3H)-酮;6-苄基-5,6,7,8四氢吡咯并[4,3-D]嘧啶-4(3H)-酮;6-苄基-5,6,7,8-四氢吡啶并[4,3-D]嘧啶-4(3H)-酮 6-BENZYL-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDIN-4(3H)-ONE
英文名称:
6-苄基-5,6,7,8四氢吡咯并[4,3-D]嘧啶-4(3H)-酮
英文别名:
6-benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one;6-Benzyl-5,6,7,8-tetrahydro-3H-pyrido[4,3-d]pyrimidin-4-one;3-d]pyriMidin-4(3H)-one;6-benzyl-5;6-benzyl-3H,4H,5H,6H,7H,8H-pyrido[4,3-d]pyriMidin-4-one;6-Benzyl-5,6,7,8-tetrahydro-1H-pyrido[4,3-d]pyriMidin-4-one;Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyriMidin-4(3H)-one;6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)
密度:
1.27±0.1 g/cm3(Predicted)
熔点:
-165-166.5 °C(Solv: acetone (67-64-1))
沸点:
406.5±55.0 °C(Predicted)
产品用途:
6-苄基-5,6,7,8四氢吡咯并[4,3-D]嘧啶-4(3H)-酮作为新的P2X3受体拮抗剂被用于发现和优化喹唑啉酮类化合物。